BIOCHINA

News

Nearly $2 Billion Deal! Chinese-Origin TCE Secures Another Overseas Licensing Agreement

Details

U-Yi Biotech Raises Tens of Millions of RMB in Series A Financing to Expand Serum-Free Culture Media Platform

Details

Haisco Licenses Two Clinical-Stage Small-Molecule Assets to Nuvectis in Deal Worth Up to US$1.46 Billion

Details

Barty Medical Raises Nearly RMB 200 Million in Series D Financing to Accelerate Commercialization of Vascular Interventional Devices

Details

Over US$1 Billion! Eli Lilly Licenses AlzeCure’s Alzheimer’s Small-Molecule Candidate ACD680

Details

KauseuBie Secures Pre-A Financing to Scale Up Al-Driven Synthetic Biology Manufacturing

Details

ADICON and Gan & Lee Pharmaceuticals Join Forces to Advance ICL + CRO Innovation

Details

YolTech Therapeutics Secures Nearly RMB 500 Million Series C Financing to Accelerate In Vivo Gene Editing Pipeline

Details

$3.05 Billion Licensing Deal! Haisco Enters Global Collaboration with Eli Lilly

Details

$180 million Series A – cAMPfield Therapeutics launches as a NewCo focused on inflammation and immunology.

Details

1 2 3 4 5 Next